A comparison of Sars-cov2 antibody kinetics and durability of two doses of mRNA vaccines at 3 and 6 months post vaccination in Liver transplant recipients
Latest Information Update: 01 Aug 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 01 Aug 2022 New trial record
- 08 Jun 2022 Results presented at the 2022 American Transplant Congress